United States will offer about 300,000 doses of Monkeypox vaccine in the coming weeks

The Biden administration has announced a “nationwide vaccination strategy” to stem the spread of monkeypox in the United States.

Yesterday, senior federal health officials – including Dr. Rochelle Valensky, director of the Centers for Disease Control and Prevention, and Dr. Ashish Jha, COVID-19 Response Coordinator at the White House – presented the administration’s plan to reporters. Increasing the availability of vaccines for monkeypox.

• Monkeypox is spreading in Latin America
• Smallpox drug makers recieve new orders as monkeypox spreads

The Department of Health and Human Services will provide 296,000 doses in the coming weeks. Within this amount, 56,000 doses will be made available immediately. And by the end of the year, a total of 1.6 million doses are expected to be available in the United States. The vaccine being distributed is the JYNNEOS vaccine, which is given in two doses at 28-day intervals.

According to reports, there are now more than 300 confirmed cases of Monkey Pox in the United States.

No deaths have been reported from Monkey Pox in the United States during the current outbreak.

Who will be vaccinated?

According to the HHS press release, under this new strategy, the vaccine will now be given to those who have confirmed monkeypox. This includes “people who have had physical contact with someone who has been diagnosed with monkeypox, people who know that their sexual partner has been diagnosed with monkeypox, and men who have Had sex with men who have recently had multiple sexual partners in a place where monkeypox was known. Or in an area where monkeypox is spreading. “